Literature DB >> 22556134

Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life.

Konstantinos Kotsis1, Paraskevi V Voulgari, Niki Tsifetaki, Myrela O Machado, André F Carvalho, Francis Creed, Alexandros A Drosos, Thomas Hyphantis.   

Abstract

OBJECTIVE: Symptoms of psychological distress, including anxiety and depressive symptoms, and illness perceptions are important in determining outcome in patients with rheumatic disease. We aimed to compare psychological distress in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) and to test whether the association between psychological variables and health-related quality of life (HRQOL) was similar in the 2 forms of arthritis.
METHODS: In 83 PsA patients and 199 RA patients, we used the Patient Health Questionnaire 9 (PHQ-9), the Symptom Checklist-90-Revised, and the Brief Illness Perception Questionnaire to assess psychological variables and the World Health Organization Quality of Life Instrument, Short Form to assess HRQOL. We used hierarchical regression analysis to determine the associations between psychological variables and HRQOL after adjusting for demographic variables and disease parameters.
RESULTS: The prevalence of moderate to severe levels of depressive symptoms (PHQ-9 score ≥10) was 21.7% in PsA patients, 25.1% in RA patients, and 36.7% in those PsA patients with polyarthritis. After adjustment for severity of disease and pain, anxiety (β = -0.28) and concern about bodily symptoms attributed to the illness (β = -0.33) were independent correlates of physical HRQOL in PsA. In RA, depressive symptoms (β = -0.29) and concern about the consequences of the arthritis (β = -0.27) were independent correlates of physical HRQOL.
CONCLUSION: These findings suggest strongly that psychological factors are important correlates of HRQOL in PsA as well as in RA. Attention to patients' anxiety and their concern about numerous bodily symptoms attributed to the illness may enable rheumatologists to identify and manage treatable aspects of HRQOL in PsA.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22556134     DOI: 10.1002/acr.21725

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  20 in total

1.  [Depression and rheumatism: options for measuring depression].

Authors:  M Englbrecht; J Wendler; R Alten
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

2.  Systematic review of mental health comorbidities in psoriatic arthritis.

Authors:  Sizheng Steven Zhao; Natasha Miller; Nicholas Harrison; Stephen J Duffield; Mrinalini Dey; Nicola J Goodson
Journal:  Clin Rheumatol       Date:  2019-09-05       Impact factor: 2.980

3.  Reply: To PMID 25319745.

Authors:  Jose U Scher; Soumya Reddy; Carles Ubeda; Andrea Neimann; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

4.  Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.

Authors:  Joseph F Merola; Vivian Herrera; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2018-07-26       Impact factor: 2.980

5.  The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Authors:  Thomas Hyphantis; Konstantinos Kotsis; Niki Tsifetaki; Francis Creed; Alexandros A Drosos; André F Carvalho; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

Review 6.  Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience.

Authors:  N Betteridge; W-H Boehncke; C Bundy; L Gossec; J Gratacós; M Augustin
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-09-16       Impact factor: 6.166

Review 7.  Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature.

Authors:  Juan Carlos Torre-Alonso; Rubén Queiro; Marta Comellas; Luís Lizán; Carles Blanch
Journal:  Patient Prefer Adherence       Date:  2018-05-08       Impact factor: 2.711

8.  Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry.

Authors:  Arthur Kavanaugh; Kim Papp; Alice B Gottlieb; Elke M G J de Jong; Soumya D Chakravarty; Shelly Kafka; Wayne Langholff; Kamyar Farahi; Bhaskar Srivastava; Jose U Scher
Journal:  BMC Rheumatol       Date:  2018-09-29

9.  Incidence rates of suicidal behaviors and treated depression in patients with and without psoriatic arthritis using the Clinical Practice Research Datalink.

Authors:  Katrina Wilcox Hagberg; Lin Li; Michael Peng; Kamal Shah; Maria Paris; Susan Jick
Journal:  Mod Rheumatol       Date:  2016-02-16       Impact factor: 3.023

10.  A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor.

Authors:  Eleftherios Pelechas; Tereza Memi; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Rheumatol Ther       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.